Results: Before treatment, there was no significant difference in blood MPAR between the two groups (P> 0.05). After 24 hours, 7 days, and 28 days of treatment, the blood MPAR in both groups decreased significantly (P <0.05), and the ticagrelor group was significantly lower In the clopidogrel group (P <0.05), and with time, the rate of decline in this group was significantly greater than that in the clopidogrel group (P <0.05); its treatment effectiveness (91.78%) was significantly higher than that in the clopidogrel group (79.45 %); There is no significant difference in the incidence of MACE and bleeding between the two groups (P> 0.05).
正在翻译中..